Abstract
It has been reported that about 60% of patients commencing chemotherapy in Australia with curative intent and 47% of those receiving radiotherapy also use complementary medicine.1,2 Ingestible products are frequently used, but are often not discussed with the medical team, which increases the risk of interactions and other undesirable effects. Opportunity costs are another problem; while complementary medicine is typically used by people with cancer for supportive care and wellbeing, some use it to help treat cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 474-475 |
| Number of pages | 2 |
| Journal | Medical Journal of Australia |
| Volume | 213 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Nov 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Hospital policies on complementary medicine : a cross-sectional survey of Australian cancer services'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver